Related Experiment Video

Updated: Jun 17, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Therapeutic HPV DNA vaccines

Ken Lin1, Elena Roosinovich, Barbara Ma

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.

Immunologic Research
|January 13, 2010
PubMed

Insights

Therapeutic HPV DNA vaccines are needed to treat existing infections and lesions. Enhancing dendritic cell function is key to improving these vaccines for treating HPV-associated cancers.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Most cervical cancers are caused by Human Papillomavirus (HPV) infection.
  • Current HPV vaccines prevent infection but do not treat existing HPV infections or related lesions.
  • Therapeutic HPV vaccines are crucial for managing prevalent HPV-related diseases globally.

Purpose of the Study:

  • To review strategies for enhancing the potency of therapeutic HPV DNA vaccines.
  • To focus on modifications of dendritic cells (DCs) to improve vaccine efficacy.
  • To explore methods for treating HPV-associated malignancies with DNA vaccines.

Main Methods:

  • Review of current research on therapeutic HPV DNA vaccines.
  • Focus on dendritic cell modification strategies.
  • Analysis of methods to improve antigen presentation and immune cell interaction.

Main Results:

  • DNA vaccination is a promising platform for therapeutic HPV vaccines due to safety and immunogenicity.
  • Modifying dendritic cells can enhance vaccine potency.
  • Strategies include increasing antigen-loaded DCs, improving antigen processing, and boosting DC-T cell interactions.

Conclusions:

  • Improving therapeutic HPV DNA vaccines through dendritic cell modification is a viable strategy.
  • Enhanced DNA vaccines hold potential for treating HPV-associated premalignant lesions and malignancies.
  • Further development may lead to effective DNA vaccines for HPV-related cancers.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...